<?xml version="1.0" encoding="UTF-8" ?> 
<root> 
<content type="str">Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) has received a consensus rating of “Buy” from the five research firms that are presently  covering the firm. One research analyst  has rated the stock with a sell rating and four have given a buy rating to  the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $17.33. 
 
Several analysts have issued reports on TRHC shares. Robert W. Baird started coverage on Tabula Rasa Healthcare in a research note on Monday, October 24th. They issued an “outperform” rating and a $17.00 target price for the company. Wells Fargo &amp; Company started coverage on Tabula Rasa Healthcare in a research note on Monday, October 24th. They issued an “outperform” rating for the company. Zacks Investment Research raised Tabula Rasa Healthcare from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a research note on Tuesday, December 27th. Stifel Nicolaus began coverage on Tabula Rasa Healthcare in a research note on Monday, October 24th. They issued a “buy” rating and a $17.00 target price for the company. Finally, Piper Jaffray Companies began coverage on Tabula Rasa Healthcare in a research note on Monday, October 24th. They set an “overweight” rating and a $18.00 price objective for the company. 
 
Hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. bought a new stake in  Tabula Rasa Healthcare during the fourth quarter worth $875,000.  Sio Capital Management LLC acquired a new position in shares of  Tabula Rasa Healthcare during the third quarter worth approximately $7,303,000.  Laurion Capital Management LP acquired a new position in shares of  Tabula Rasa Healthcare during the third quarter worth approximately $430,000.  Emerald Acquisition Ltd. acquired a new position in shares of  Tabula Rasa Healthcare during the third quarter worth approximately $592,000.  Finally, Boston Partners acquired a new position in shares of  Tabula Rasa Healthcare during the third quarter worth approximately $2,682,000. 23.48% of the stock is owned by hedge funds and other institutional investors. 
 
TRADEMARK VIOLATION WARNING: This article was first  published by [[site]] and is owned by of [[site]]. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright &amp; trademark laws. The legal version of this article can be read at [[permalink]]. 
 
Shares of Tabula Rasa Healthcare ( NASDAQ:TRHC ) opened at 14.27 on Thursday. The stock has a 50 day moving average of $14.17 and a 200 day moving average of $13.20. Tabula Rasa Healthcare has a 1-year low of $10.39 and a 1-year high of $16.17. The company has a market cap of $229.76 million and a price-to-earnings ratio of 55.10. 
 
Tabula Rasa Healthcare (NASDAQ:TRHC) last issued its earnings results on Wednesday, November 9th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.03. The firm earned $24.20 million during the quarter. The firm’s revenue for the quarter was up 34.4% on a year-over-year basis.  Analysts predict that  Tabula Rasa Healthcare will post $0.23 EPS for the current year. 
 
Tabula Rasa Healthcare Company Profile 
 
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.</content> 
<sequenceId type="str">695198663127</sequenceId> 
<topics type="list"> 
<item type="dict"> 
<group type="str">Industry</group> 
<name type="str">Health care industry news</name> 
</item> 
<item type="dict"> 
<group type="str">Industry</group> 
<name type="str">Healthcare management news</name> 
</item> 
<item type="dict"> 
<group type="str">Finance</group> 
<name type="str">Finance latest</name> 
</item> 
</topics> 
<estimatedPublishedDate type="str">2017-01-29T07:43:00Z</estimatedPublishedDate> 
<title type="str">Analysts Set Tabula Rasa Healthcare Inc. (TRHC) PT at $17.33</title> 
</root>